Skip to content

Coya Therapeutics, Inc.

COYA

CIK 0001835022

← back to feed
Revenue (TTM)
$4.24M
+123.6% YoY Q1 May 2026
Net Income (TTM)
−$22.72M
−42.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.25
−29.6% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-570.3%
Q1 May 2026
Net Margin
-536.3%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$50.72M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
23.46M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings